STAT1 and lung carcinoma: Because STAT1 belongs to a genetic signature predicting lung cancer patient survival [19], effects of SIAH2 on STAT1 and the immunological control of tumorigenesis are possible, i.e. SIAH2 may act as tumor promoter via blocking STAT1.